Tatsuno, Kazuki
Yamazaki, Takahiro
Hanlon, Douglas
Han, Patrick http://orcid.org/0000-0002-0370-0729
Robinson, Eve
Sobolev, Olga
Yurter, Alp
Rivera-Molina, Felix
Arshad, Najla
Edelson, Richard L.
Galluzzi, Lorenzo
Article History
Received: 28 June 2019
Accepted: 15 July 2019
First Online: 2 August 2019
Conflict of interest
: L.G. provides remunerated consulting to OmniSEQ (Buffalo, NY, USA), Astra Zeneca (Gaithersburg, MD, USA), VL47 (New York, NY, USA) and the Luke Heller TECPR2 Foundation (Boston, MA, USA), and he is member of the Scientific Advisory Committee of OmniSEQ (Buffalo, NY, USA). R.L.E. is a shareholder in the Yale University startup company Transimmune AG. The remaining authors declare that they have no conflict of interest.
: Written consent was obtained from all healthy volunteers involved in the study, which was approved by the Yale Human Investigational Review Board under protocol number 0301023636. Animal experiments were performed according to Yale Institutional Animal Care and Use Committee approved protocols, in agreement with the National Institutes of Animal Healthcare Guidelines. The Yale animal facility is accredited by the Association for Assessment of Laboratory Animal Care.